Cargando…

Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?

Detalles Bibliográficos
Autores principales: Ferrara, Francesco, De Rosa, Francesco, Vitiello, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319216/
https://www.ncbi.nlm.nih.gov/pubmed/32838149
http://dx.doi.org/10.1007/s42399-020-00375-0
_version_ 1783551011043934208
author Ferrara, Francesco
De Rosa, Francesco
Vitiello, Antonio
author_facet Ferrara, Francesco
De Rosa, Francesco
Vitiello, Antonio
author_sort Ferrara, Francesco
collection PubMed
description
format Online
Article
Text
id pubmed-7319216
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73192162020-06-29 Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? Ferrara, Francesco De Rosa, Francesco Vitiello, Antonio SN Compr Clin Med Covid-19 Springer International Publishing 2020-06-26 2020 /pmc/articles/PMC7319216/ /pubmed/32838149 http://dx.doi.org/10.1007/s42399-020-00375-0 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Covid-19
Ferrara, Francesco
De Rosa, Francesco
Vitiello, Antonio
Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
title Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
title_full Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
title_fullStr Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
title_full_unstemmed Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
title_short Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
title_sort worldwide recommendations and therapies for multiple sclerosis: are they safe in the covid-19 pandemic period?
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319216/
https://www.ncbi.nlm.nih.gov/pubmed/32838149
http://dx.doi.org/10.1007/s42399-020-00375-0
work_keys_str_mv AT ferrarafrancesco worldwiderecommendationsandtherapiesformultiplesclerosisaretheysafeinthecovid19pandemicperiod
AT derosafrancesco worldwiderecommendationsandtherapiesformultiplesclerosisaretheysafeinthecovid19pandemicperiod
AT vitielloantonio worldwiderecommendationsandtherapiesformultiplesclerosisaretheysafeinthecovid19pandemicperiod